Anticoagulants
- Active ingredient (INN)
- pentoxifylline
- Composition (active ingredients)
- pentoxifylline - 20,0 mg
- Фармакотерапевтическая группа
- vasodilator
- Pharmacotherapeutic group
- ampoules 20 mg/ml 5 ml № 5, 10
- Сonditions of supply
- on prescription
Indications
Indications
Indicated for use in adults with a diagnosis of:- peripheral arterial occlusion disease of atherosclerotic or diabetic origin (for example, intermittent claudication, diabetic angiopathy);
- trophic disorders (for example, trophic ulcers of the legs, gangrene);
- cerebrovascular accident;
- circulatory disorders in the retina and choroid of the eye;
- otosclerosis, degenerative changes against the background of the pathology of the vessels of the inner ear and hearing loss.
Dosage regimen
Dosage regimen
The dose and method of application are determined by the severity of circulatory disorders, as well as based on the individual tolerance of the drug. The dosage is set by the doctor in accordance with the individual characteristics of the patient. In patients with renal failure (creatinine clearance less than 30 ml/min), it is necessary to reduce the dosage by 30-50%, which depends on the individual tolerance of the drug to the patient.
In elderly patients, a dose reduction (increased bioavailability and decreased excretion rate) may be required.
Contraindications
There are contraindications, consult with a specialist before use
